A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: darolutamide
Sponsor: Translational Research in Oncology
Collaborators: Bayer